Article: Confirmed clinical benefit of BRAF and MEK co-inhibition in BRAF-mutant metastatic melanoma: updated data from coBRIM and BRIM7

€3.03

SKU: product-article-11300 Category: General

Description
Reviews (0)

Description

Confirmed clinical benefit of BRAF and MEK co-inhibition in BRAF-mutant metastatic melanoma: updated data from coBRIM and BRIM7

Reviews

There are no reviews yet.

Be the first to review “Article: Confirmed clinical benefit of BRAF and MEK co-inhibition in BRAF-mutant metastatic melanoma: updated data from coBRIM and BRIM7”

You must be logged in to post a review.

Top

Article: Confirmed clinical benefit of BRAF and MEK co-inhibition in BRAF-mutant metastatic melanoma: updated data from coBRIM and BRIM7

Description

Reviews

Related products

Article: Highlights in squamous cell carcinoma of the head and neck

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in breast cancer

Article: Highlights in digestive oncology